QDOLO™ oral solution contains tramadol HCI 5mg/1mL1 and is the first and only FDA-approved oral liquid form of tramadol.2
QDOLO is indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Limitations of Use: Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, reserve QDOLO for use in patients for whom alternative treatment options (e.g., non-opioid analgesics):
- Have not been tolerated or are not expected to be tolerated.
- Have not provided adequate analgesia or are not expected to provide adequate analgesia.
- QDOLO [prescribing information]. Athens, GA: Athena Bioscience, LLC; 2020.
- U.S. Food & Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Accessed, October 1, 2020.